📰 Emerald Study News
Emerald Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Emerald Study. Real-time updates on events, politics, business and more.
January 30, 2024
Erica L. Mayer, MD, MPH, discusses the role of elacestrant in the breast cancer treatment landscape and provides clinical insights on its safety profile.
January 24, 2024
Kevin Kalinsky, MD, MS, gives an overview of recent data from the EMERALD trial investigating elacestrant in patients with ER+/HER2- advanced breast cancer.
August 1, 2023
Drs Vidula and Lu review the potential impact of cardiovascular health associated with oral selective estrogen receptor degraders (SERDs) and discuss how the risk of menopausal symptoms differ between oral SERDs and other endocrine therapies.